Baidu
map

那些年血常规踩过的坑

2019-05-31 刘西西 检验医学网

前两天朋友圈被中央电视台一个血常规的案子刷屏了。一个河南的农妇由于做血常规血小板少被当地医院诊断为免疫性血小板减少性紫癜,然后开始痛苦的三年治疗,家里承受了巨大的经济和精神的负担,却仍无好转,甚至更严重了,抱着最后一丝希望他们去了河南省人民医院,结果诊断结果让所有人目瞪口呆,这里的医生居然说她没病,血小板是正常的。那么到底是怎么回事呢?原来这个妇女体内对血常规紫管里的抗凝剂EDTA过敏,导致她抽出

前两天朋友圈被中央电视台一个血常规的案子刷屏了。

一个河南的农妇由于做血常规血小板少被当地医院诊断免疫性血小板减少性紫癜,然后开始痛苦的三年治疗,家里承受了巨大的经济和精神的负担,却仍无好转,甚至更严重了,抱着最后一丝希望他们去了河南省人民医院,结果诊断结果让所有人目瞪口呆,这里的医生居然说她没病,血小板是正常的。那么到底是怎么回事呢?

原来这个妇女体内对血常规紫管里的抗凝剂EDTA过敏,导致她抽出的血小板大量聚集在一起,而机器识别不出聚集的血小板,做出了血小板低的结果。这个在临床上叫做EDTA依赖性血小板假性减少。

而医院从化验到临床医生盲目相信机器的结果,第一关临检人员没把握好,第二关临床医生没把握住,导致病人承受了本该属于她的痛苦。这是很不应该的。

细思极恐,做个简单的血常规怎么会惹出这么大的麻烦呢?第一不复片,第二不联系临床症状!

最近笔者也碰到一例这样的:

孕妇血小板24,复查也是这么多。



那么就真的是这么多么?按照复查规则,复片结果如下,油镜下大量血小板聚集。



于是跟临床医生联系,这个孕妇没有任何症状,让护士重新抽了两管蓝管和绿管,蓝管枸橼酸钠抗凝,绿管肝素抗凝,上机做,肝素做出来血小板71,枸橼酸钠做出来血小板138,血常规结果如下:


枸橼酸钠抗凝管结果


肝素抗凝管结果

还是取血涂片,结果肝素的那管镜下血小板仍然凝集,枸橼酸钠那管血小板没有凝集正常分布,看来她是肝素和EDTA同时依赖,这个比EDTA依赖性减少还要罕见。

于是和临床医生沟通后发出正常的血小板结果,一个简单的复片就避免了可能出现的误诊和误判。所以请大家作为化验人员,把好第一关,不要偷懒,严格遵守复检规则,认真的对待每一个标本,因为这后面代表着无数个家庭和希望。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=367146, encodeId=353536e1464a, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 02 01:19:56 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367107, encodeId=4b5c36e1071e, content=推片复查有必要,不能偷懒, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:29:44 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367102, encodeId=332636e10244, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Sat Jun 01 14:16:17 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367101, encodeId=a25536e10179, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sat Jun 01 13:36:14 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367081, encodeId=a88636e0814c, content=学习不忘初心、牢记使命”, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Jun 01 06:34:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-02 飛歌

    学习了很有用不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=367146, encodeId=353536e1464a, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 02 01:19:56 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367107, encodeId=4b5c36e1071e, content=推片复查有必要,不能偷懒, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:29:44 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367102, encodeId=332636e10244, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Sat Jun 01 14:16:17 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367101, encodeId=a25536e10179, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sat Jun 01 13:36:14 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367081, encodeId=a88636e0814c, content=学习不忘初心、牢记使命”, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Jun 01 06:34:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 133d9d3cm85暂无昵称

    推片复查有必要,不能偷懒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=367146, encodeId=353536e1464a, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 02 01:19:56 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367107, encodeId=4b5c36e1071e, content=推片复查有必要,不能偷懒, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:29:44 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367102, encodeId=332636e10244, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Sat Jun 01 14:16:17 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367101, encodeId=a25536e10179, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sat Jun 01 13:36:14 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367081, encodeId=a88636e0814c, content=学习不忘初心、牢记使命”, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Jun 01 06:34:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 123592b0m72暂无昵称

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=367146, encodeId=353536e1464a, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 02 01:19:56 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367107, encodeId=4b5c36e1071e, content=推片复查有必要,不能偷懒, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:29:44 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367102, encodeId=332636e10244, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Sat Jun 01 14:16:17 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367101, encodeId=a25536e10179, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sat Jun 01 13:36:14 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367081, encodeId=a88636e0814c, content=学习不忘初心、牢记使命”, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Jun 01 06:34:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 txqjm

    谢谢了,学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=367146, encodeId=353536e1464a, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jun 02 01:19:56 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367107, encodeId=4b5c36e1071e, content=推片复查有必要,不能偷懒, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210319/8535b99e11f8425ea0d00535473afd64/2d2121d6fde646e4b4ea8d46ebb52b92.jpg, createdBy=e2423643634, createdName=133d9d3cm85暂无昵称, createdTime=Sat Jun 01 15:29:44 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367102, encodeId=332636e10244, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=193b2402424, createdName=123592b0m72暂无昵称, createdTime=Sat Jun 01 14:16:17 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367101, encodeId=a25536e10179, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sat Jun 01 13:36:14 CST 2019, time=2019-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367081, encodeId=a88636e0814c, content=学习不忘初心、牢记使命”, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRkia1DP5MpwEgtXo1XhXA11xD6MWKxunAZFXKSNic0fWHUQx83oNHPlRMxxIctM83QKeCLkJpMibibiaC/0, createdBy=7e581734408, createdName=深海的鱼, createdTime=Sat Jun 01 06:34:38 CST 2019, time=2019-06-01, status=1, ipAttribution=)]
    2019-06-01 深海的鱼

    学习不忘初心、牢记使命”

    0

相关资讯

血红蛋白异常增高,竟是……

在血常规检验中,血红蛋白异常(HGB)增高的病人时有出现,但“真高”or“假高”,有时候需要认真鉴别,否则很可能造成检验结果的误判,甚至造成纠纷。那么下面就跟大家分享几种“真假”HGB案例。

抽血究竟查了什么?血常规背后的大学问

1 先搞懂啥叫参考范围 拿到化验单后,大家最关心的是自己的检验结果正不正常,换句换说在不在正常值的范围内。先说说这个概念,过去叫正常值,现在改为参考范围。患者的检验结果在参考范围之外,是不是一定就有问题呢?答案是否定的。

冷冷冷!血常规标本也怕冷

2018年12月18日,检验科收到一份“冷”的血常规标本,来自呼吸重症监护室。EDTA抗凝血在血液分析仪上,白细胞系统及白细胞分类均可正常检出,血红蛋白结果也正常,但却出现红细胞计数与血红蛋白比值严重不符的情况,工作人员肉眼可看到小的凝集,将标本放置37℃水浴10min后计数正常。

这样的血常规结果要注意了!

患者,女,57岁,因乏力、低热3天就诊,血常规结果除血红蛋白和红细胞略减少外,其余结果未见明显异常(图1,2),如果从数值和散点图来判断,未触犯复检规则,同时CRP为65mg/L,如果由您审核这份报告,能直接签发吗?假如需要复检,又该做些什么呢?

儿童检验新三大常规:血常规+CRP+?

一、儿科门诊就诊特点 —以感染性疾病为主,其中病毒感染占多数

动脉血和静脉血常规生化项目是否存在差异?

一、背景&目的 ICU重症患者应用的有创性治疗和检测较多,因此动脉留置导管在ICU病房应用非常广泛,可以为危重病患者提供迅速、直接、准确的血压数据,并可以频繁抽取动脉血标本进行血气分析。

Baidu
map
Baidu
map
Baidu
map